AP-1 complex (TGN)
CELLS 3.1 Introduction
3.3 Western blotting across eosinophil subfractions 1 Introduction
A range o f approaches using synaptic vesicle and Golgi membranes as well as
yeast secretion mutants have led to a model o f vesicle docking and fusion being
proposed known as the SNARE hypothesis. Although the original SNARE hypothesis
has undergone considerable reassessment and refinement, SNARE proteins are still
thought to provide a core mechanism to specifically pair membrane compartments.
Many v- and t-SNARES have been identified in yeast, plants and animals. They have
also been localised to specific subcellular compartments including the ER, endosomes
and plasma membrane, but little is known o f their role in secretory lysosome docking
and fusion events during regulated secretion in haematopoietic cells. Antibodies to
key components o f this complex, as well as other synaptic vesicle proteins also
thought to play a role in regulation o f membrane fusion events such as Rab3,
synaptophysin and synaptobrevin are now available. Therefore it should be possible to
couple subcellular fractionation techniques with western blotting to determine if any
o f these components are present on the eosinophil granule. Identification o f granule
docking and fusion components would be an initial step in understanding the
underlying mechanism o f regulated secretion in haematopoietic cells.
3.3.2 Results
After fractionation, ISOpl o f each eosinophil subffaction was loaded onto an
7.5-13% polyacrylamide gel, then stained with coomassie blue. A typical gel across
an eosinophil subfractionation is shown in figure 3.3. The majority o f protein was
present in cytosolic fractions, although granule fractions also contained high amounts
o f a few proteins with molecular weights o f approximately, 50, 14 and 18kDa. These
corresponded to known granule content proteins, eosinophil peroxidase large subunit,
major basic protein and eosinophil derived neurotoxin (Hamann et al, 1991). Very few other bands were visible in the granule fractions. Furthermore, electron
micrographs o f eosinophil granules demonstrate the abundance o f granule content and
highlight the high ratio o f granule lumen content to membrane in these organelles
Fraction number
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
f-A
Figure 3.3: Coomassie stained polyacrylamide gel of across eosinophil subfractions. An equal volume of each fraction was loaded onto each lane with protein levels of 2.5- 40pg/well.
kDa 66 Lane 2 3 35 21 14
e
25 20 > Ü CD CO O o 0 2 4 6 8 10 12 14 16 18 20 22 24-o - EPO
-e - AP
fraction no. kDa < 66Figure 3.4: Synaptic vesicle protein expression across hum an eosinophil subfractions, (a) Western blot showing expression of synaptic vesicle proteins in human brain. VAMP (synaptobrevin) (lane 1); SNAP25 (lane 2); syntaxinl (lane 3); Rab3 (lane 4); synapsinl (lane 5) (b) marker enzymes across human eosinophil subfractions. EPO (eosinophil peroxidase); AP (alkaline phosphatase), (c) Western blot showing expression of synapsin I across eosinophil subfractions.
In an attempt to identify granule fusion machinery components, Western blots
across the subfractionation were prepared. 150|ul/well o f each fraction was loaded
onto an 7.5-13% polyacrylamide gel, which was then transferred onto ECL-
nitrocellulose as described in chapter 2. Table 3.1 details the synaptic vesicle protein
antisera tested on eosinophil subtractions and the results obtained. These antisera all
reacted positively when tested against a human brain western blot (Fig. 3.4a). With
the exception o f synapsin I however, none o f these antisera reacted positively with the
eosinophil subtractions (Fig. 3.4c). Synapsin I localised to cytosolic fractions and to
light membrane fractions corresponding to plasma membrane and Golgi membranes
(Fig. 3.4b). No synapsin immunoreactivity however was localised to the ER,
lysosomal or granule fractions.
Antisera to protein Specificity
Rab3(a-d) Human, rat, invertebrates
SNAP-25 Human, rat
Synaptobrevin Human, pig
Syntaxin Human, pig, hamster, rat
Synapsin I Human, bovine, rat
Table 3.1: Summary o f eosmophil granule immunoblot analysis o f synaptic vesicle complex components. Sources o f antibodies are listed in chapter 2.
3.3.2 Discussion
Despite exhaustive probing for members o f the synaptic vesicle fusion
complex, none o f those tested with the exception o f synapsin I reacted against blots o f
human eosinophil subfractions. There are a number o f possible explanations for these
observations. The first is that the secretory lysosome o f haematopoietic cells utilises a
different mechanism for docking and fusion with the plasma membrane. It is possible
however that cells o f this lineage use homologues o f the known docking and fusion
machinery components, that are not recognised by available antibodies. A third
number o f granules per cell means that insufficient membrane protein has been loaded
onto the gel for detection by western blotting.
The demonstration o f synapsin I immunoreactivity in eosinophil subtractions
is intriguing. Synapsin I immunoreactivity was not observed in the granule-enriched
fractions. Synapsins are a multigene family o f neuron-specific phosphoproteins. They
interact in vitro with lipid and protein components o f synaptic vesicles and with cytoskeletal proteins including actin (Hilfiker et al., 1999). These observations have led to the hypothesis that synapsins tether synaptic vesicles to each other and to the
actin-based cytoskeleton, to maintain a pool o f vesicles in the vicinity o f the active
zone. Although synapsins are widely accepted to have neuronal specific expression,
there is recent evidence suggesting that synapsin I is also associated with the insulin
secretory granules o f MIN6 cells and it has also been detected by PCR in normal rat
islets (Matsumoto et a l, 1999). Synapsin I immunoreactivity has not previously been observed in cells o f the haematopoietic lineage, although further studies in this
laboratory demonstrated synapsin I mRNA expression by Northern blotting (C.
Paddon, personal communication). The absence o f synapsin immunoreactivity from
granule fractions, but its presence in cytosolic and light membrane fractions, suggests
that synapsins may be involved in the exocytosis o f small secretory vesicles, although
as o f yet there is no further evidence for this.
Parallel studies using guinea pig eosinophils also demonstrate the absence o f
synaptic vesicle proteins in the eosinophil (Lacy et a l, 1995) and are in agreement with the observations described here. This study also noted the absence o f the synaptic
vesicle proteins synaptotagmin and cellubrevin. During the course o f this study, the
presence o f the t-SNARE syntaxin 4, VAMP-2 and the 39kDa isoform o f the
secretory carrier membrane protein (SCAMP) have been demonstrated in neutrophils
(Brumell et ah, 1995). Syntaxin 4 was localised predominantly to the plasma membrane. VAMP-2 was present in tertiary granules and secretory vesicles, but
largely absent from primary (lysosomal) granules and secretory vesicles. SCAMP was
also absent from primary granules, but was localised to secondary and tertiary
granules and secretory vesicles. The apparent difference in synaptic vesicle marker
expression in eosinophils and neutrophils may be due to the presence o f multiple
that none o f these proteins were present on the secretory lysosome o f the neutrophil.
This suggests that either these proteins are present at undetectable levels, that
secretory lysosomes use homologues o f these proteins, or that the secretory lysosome
utilises a different control mechanism for membrane fusion during degranulation. In
attempt to address these possibilities other approaches are necessary that do not rely
3.4 Direct identification of proteins from eosinophil subfractions by mass